|More from: | Investopedia |||
Cannabis stocks ripped higher in the third quarter of 2018, underpinned by Canada’s national legalization in mid-October and Tilray, Inc.’s (TLRY) deal with the U.S. Drug Enforcement Administration to import pot for medical research. Dow component The Coca-Cola Company (KO) added to optimism at the time, talking with Vancouver-based Aurora Cannabis about a beverage containing CBD, the non-psychoactive but medically promising plant extract.
Bubble warnings were ignored during the rapid advance, encouraging a low-skilled trading crowd to jump on board, hoping for the next Amazon.com, Inc. (AMZN). Not surprisingly, pot stocks topped out quickly and turned sharply lower, trapping dumb money in a rapid decline reminiscent of the cryptocurrency plunge. Fortunately for remaining bulls, price action has improved
About | Investopedia |
Investopedia is the world’s leading source of financial content on the web, with more than 30 million unique visitors and 90 million page views each month.
Wholly owned by IAC (NASDAQ: IAC), Investopedia is the largest financial education website in the world. Powered by a team of data scientists and financial experts, Investopedia offers timely, trusted and actionable financial information for every investor, from early investors to financial advisors to high net worth individuals. Investopedia is operated by IAC Publishing, a collection of some of the web’s largest and most trusted digital media brands. For the latest in financial news and information, visit www.investopedia.com.